Analyst Michael Yee of Jefferies maintained a Buy rating on Biogen (BIIB – Research Report), retaining the price target of $250.00. Michael Yee has given his Buy rating due to a combination of factors ...
Naloxone is a life-saving medication which helps reverse the effects of an opioid overdose. Improving naloxone access is a central pillar of the federal response to the worsening opioid crisis in the ...
× Zoomable Statistic: Select the range in the chart you want to zoom in on.
Finally, the team conducted a specific workshop on the new Frontal system. Nine Indaux distributors in India visited the industrial facilities of Aia and Getaria through a reverse mission organized by ...
American Tire Distributors (ATD) has commenced voluntary Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware. The restructuring plan aims to transition ownership of the ...
Oct 23 (Reuters) - American Tire Distributors, the largest seller of replacement tires in the U.S., filed for bankruptcy protection late Tuesday for the second time since 2018, seeking to sell ...
Tech companies think they can reverse climate change with fancy new tools to take carbon dioxide out of the atmosphere. But new research throws cold water on the idea that cooling the planet ...
During this process, ATD will continue to operate across its nationwide distribution network as the organization remains focused on supporting its manufacturer partners and providing its customers ...
29). That’s up from 9.5 percent in August and marks the company’s ninth time in the top spot in the 11 months Nielsen has shared distributor data. Huge gains for ESPN and ESPN2 — both of ...
Takeda, a Japanese pharmaceutical company with US headquarters in Cambridge, has announced the latest of several rounds of layoffs it’s been conducting this year, bringing the total to nearly ...
A pharmaceutical body has warned of potential shortages of some medicines in Northern Ireland unless there is a delay to the implementation of the Windsor Framework. The framework is the post ...
The pharma industry has had a difficult time solving the issue of achieving greater productivity without significantly increasing the cost it takes to discover and commercialise new products.